Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Newly developed MRSA medium].

F Taguchi1, T Saito-Taki, S Okuda

  • 1Department of Microbiology, Kitasato University School of Hygienic Sciences, Japan.

Nihon Saikingaku Zasshi. Japanese Journal of Bacteriology
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in an ultra-short-term skin carcinogenesis bioassay using rasH2 mice.

Veterinary pathology·2013
Same author

Studies of severe acute respiratory syndrome coronavirus pathology in human cases and animal models.

Veterinary pathology·2010
Same author

Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same author

An effective iodide formulation for killing Bacillus and Geobacillus spores over a wide temperature range.

Journal of applied microbiology·2004
Same author

Clustering of C-type lectin natural killer receptor-like loci in the bony fish Oreochromis niloticus.

Scandinavian journal of immunology·2004
Same author

Expression profile of mRNAs from human pancreatic islet tumors.

Journal of molecular endocrinology·2003
Same journal

[Poster].

Nihon saikingaku zasshi. Japanese journal of bacteriology·2026
Same journal

[Flash Talk].

Nihon saikingaku zasshi. Japanese journal of bacteriology·2026
Same journal

[ICD].

Nihon saikingaku zasshi. Japanese journal of bacteriology·2026
Same journal

[Educational Lecture].

Nihon saikingaku zasshi. Japanese journal of bacteriology·2026
Same journal

[Symposium].

Nihon saikingaku zasshi. Japanese journal of bacteriology·2026
Same journal

[Special Lecture].

Nihon saikingaku zasshi. Japanese journal of bacteriology·2026
See all related articles

A new MR(SA)2 medium rapidly identifies methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MR-CNS) from clinical samples. This selective agar utilizes egg-yolk and antibiotic properties for accurate differentiation.

Area of Science:

  • Microbiology
  • Clinical Diagnostics
  • Bacteriology

Context:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat.
  • Rapid and accurate identification of MRSA from clinical specimens is crucial for effective treatment and infection control.
  • Existing diagnostic methods can be time-consuming, delaying appropriate patient management.

Purpose:

  • To develop and evaluate a novel selective medium, MR(SA)2, for the rapid and accurate identification of MRSA.
  • To assess the efficacy of MR(SA)2 in differentiating MRSA from other microorganisms, including methicillin-resistant coagulase-negative staphylococci (MR-CNS).
  • To determine optimal incubation conditions for MR(SA)2 medium.

Summary:

  • The MR(SA)2 medium is a modified Müller-Hinton agar containing NaCl, mannitol, bromcresol purple, egg-yolk, oxacillin, and ceftisoxime.

Related Experiment Videos

  • MRSA strains exhibited similar growth on MR(SA)2 medium at both 30°C and 37°C.
  • The medium facilitates differentiation based on colony morphology and egg-yolk reaction, distinguishing MRSA from MR-CNS and other microbes.

    • Impact:

    • The MR(SA)2 medium offers a potentially faster and more efficient method for MRSA detection in clinical settings.
    • This advancement could lead to quicker initiation of targeted antibiotic therapy, improving patient outcomes.
    • The selective nature of the medium aids in distinguishing between different types of resistant staphylococci, supporting epidemiological surveillance.